Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Trastuzumab Injection

Approval Number

S20160056

CompanyGENENTECH INC

Registration Date

December 9, 2016

Previous Approval Numbers

S20150068

Drug Information

Generic Name

注射用曲妥珠单抗

Trade Name

赫赛汀

Dosage Form

注射剂

Strength

440mg(20ml)/瓶

Drug Type

生物制品

Registration Date

December 9, 2016

Expiry Date

December 22, 2020

Company Information

Applicant Company

Company NameGENENTECH INC

Company Address

Schoenmattstrasse 2, 4153 Reinach,Switzerland

Manufacturing Company

Company NameGENENTECH INC

Company Address

South San Francisco, CA 94080 ,USA

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用曲妥珠单抗 - NMPA 批准文号 | MedPath